| John J Mcgetrick Jr, MD | |
|
810 N Rose Ave, Kissimmee, FL 34741-4944 | |
| (407) 943-7100 | |
| (407) 943-7328 |
| Full Name | John J Mcgetrick Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 14 Years |
| Location | 810 N Rose Ave, Kissimmee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497071047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | ME124033 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flagler Hospital | Saint augustine, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ackerman Cancer Center Pa | 3779541362 | 10 |
News Archive
Mental health experts in the past three decades have emphasized the dangers of post-partum depression for mothers, but a University of Kansas researcher says expanding awareness of several other perinatal mental health conditions is important for all new parents, including fathers.
Women's perception of their cancer risk appears to vary by race and may affect how likely they are to undergo screenings, particularly for colon cancer, according to a report in the April 14 issue of Archives of Internal Medicine.
A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 9 days ago
| Entity Name | Ackerman Cancer Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265111629 PECOS PAC ID: 3779541362 Enrollment ID: O20041229000504 |
News Archive
Mental health experts in the past three decades have emphasized the dangers of post-partum depression for mothers, but a University of Kansas researcher says expanding awareness of several other perinatal mental health conditions is important for all new parents, including fathers.
Women's perception of their cancer risk appears to vary by race and may affect how likely they are to undergo screenings, particularly for colon cancer, according to a report in the April 14 issue of Archives of Internal Medicine.
A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 9 days ago
| Entity Name | St Vincent's Ambulatory Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417987124 PECOS PAC ID: 2860411188 Enrollment ID: O20051116000430 |
News Archive
Mental health experts in the past three decades have emphasized the dangers of post-partum depression for mothers, but a University of Kansas researcher says expanding awareness of several other perinatal mental health conditions is important for all new parents, including fathers.
Women's perception of their cancer risk appears to vary by race and may affect how likely they are to undergo screenings, particularly for colon cancer, according to a report in the April 14 issue of Archives of Internal Medicine.
A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John J Mcgetrick Jr, MD 810 N Rose Ave, Kissimmee, FL 34741-4944 Ph: (407) 943-7100 | John J Mcgetrick Jr, MD 810 N Rose Ave, Kissimmee, FL 34741-4944 Ph: (407) 943-7100 |
News Archive
Mental health experts in the past three decades have emphasized the dangers of post-partum depression for mothers, but a University of Kansas researcher says expanding awareness of several other perinatal mental health conditions is important for all new parents, including fathers.
Women's perception of their cancer risk appears to vary by race and may affect how likely they are to undergo screenings, particularly for colon cancer, according to a report in the April 14 issue of Archives of Internal Medicine.
A Fox Business report shows the health overhaul is cutting deeper into drug and device makers' profits than many expected. Research & development programs are already being drastically scaled back.
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the urinary bladder.
› Verified 9 days ago
Dr. Sarat C Sabharwal, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1056 E Osceola Pkwy, Kissimmee, FL 34744 Phone: 407-808-5656 Fax: 407-809-5554 | |
Dr. David A Melendez, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 591 Oak Commons Blvd, Kissimmee, FL 34741 Phone: 407-943-7100 Fax: 407-943-7328 | |
Zaid Atir Fadhli, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2400 N Orange Blossom Trl, Suite 210, Kissimmee, FL 34744 Phone: 407-933-2500 Fax: 407-933-0586 | |
Richard Ian Silver, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 591 Oak Commons Blvd, Kissimmee, FL 34741 Phone: 407-943-7100 Fax: 407-943-7328 | |
Dr. Shady Saikali, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 380 Celebration Pl Ste 401, Kissimmee, FL 34747 Phone: 407-303-4673 | |
Mr. Edward J Kata Jr., M.D Urology Medicare: Accepting Medicare Assignments Practice Location: 2400 N Orange Blossom Trl Ste 102, Kissimmee, FL 34744 Phone: 407-944-4947 Fax: 407-874-7802 |